Compounds > 17 alpha-hydroxyprogesterone caproate
Page last updated: 2024-09-05

17 alpha-hydroxyprogesterone caproate and Endometrial Hyperplasia

17 alpha-hydroxyprogesterone caproate has been researched along with Endometrial Hyperplasia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamernitskii, AV; Kareva, EN; Kirpichnikova, NV; Levina, IS; Mgdesyan, KK; Ovchinnikova, EV1
Agostini, R; Casini, ML; Costabile, L; Marzano, F; Paragona, M; Unfer, V1
Bokhman, IaV; Tkeshelashvili, VT; Vishnevskiĭ, AS1
Charkviani, L; Charkviani, T; Kobiashvili, H1
Litvinenko, TM1
Al-Khalabi, A; Tabakman, IuIu; Vasil'eva, IA1

Other Studies

6 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Endometrial Hyperplasia

ArticleYear
Relative binding activity of new antigestagens with progesterone receptors in human hyperplastic endometrium.
    Bulletin of experimental biology and medicine, 2002, Volume: 134, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Endometrial Hyperplasia; Estrogen Receptor Modulators; Female; Humans; Hydroxyprogesterones; In Vitro Techniques; Kinetics; Middle Aged; Receptors, Progesterone

2002
Efficacy and safety of 17alpha-hydroxyprogesterone caproate in hormone replacement therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 21, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Calcium; Climacteric; Creatinine; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Ultrasonography; Uterine Hemorrhage

2005
[Planning of the treatment of atypical hyperplasia of the endometrium in patients with uterine myoma].
    Voprosy onkologii, 1984, Volume: 30, Issue:3

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Age Factors; Chlormadinone Acetate; Combined Modality Therapy; Contraceptives, Oral, Combined; Dilatation and Curettage; Drug Combinations; Drug Therapy, Combination; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Humans; Hydroxyprogesterones; Leiomyoma; Mestranol; Middle Aged; Norethindrone; Time Factors; Uterine Neoplasms

1984
Organ preserving method in the management of atypical endometrial hyperplasia.
    European journal of gynaecological oncology, 2001, Volume: 22, Issue:4

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Endometrial Hyperplasia; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pregnancy; Progesterone Congeners

2001
[Comparative evaluation of the effectiveness of various methods of treating endometrial hyperplasia].
    Akusherstvo i ginekologiia, 1985, Issue:2

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Combined Modality Therapy; Cryosurgery; Drug Therapy, Combination; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Hydroxyprogesterones; Methyltestosterone; Middle Aged

1985
[Results of treatment of atypical endometrial hyperplasia].
    Akusherstvo i ginekologiia, 1987, Issue:7

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Contraceptives, Oral, Combined; Endometrial Hyperplasia; Ethynodiol Diacetate; Female; Follow-Up Studies; Humans; Hydroxyprogesterones; Mestranol; Norethynodrel

1987